Guardant Health (GH) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Guardant Health (GH) is Neutral.

The composite score behind that read is +0.15, weighing +0.42 of bullish evidence against -0.32 bearish.

Guardant Health last closed at $167.47, +1.15% on the session.

Against the IVW growth benchmark the position is +0.35% over the forecast window.

The read is built from 15 underlying insights — 8 bullish and 7 bearish.

Agreement across those insights is 53%.

2 graded predictions for GH so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Guardant Health in the 98th percentile on return on equity, where 100 is best.

Guardant Health is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $22.22B.

StockMap tracks Guardant Health as the 13th largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite Guardant Health ranks 4th of 85 in the group, against a group median of +0.00.